D'ALESSIO, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 583
NA - Nord America 440
EU - Europa 424
SA - Sud America 59
AF - Africa 41
Totale 1.547
Nazione #
US - Stati Uniti d'America 407
RU - Federazione Russa 228
SG - Singapore 204
CN - Cina 96
HK - Hong Kong 93
VN - Vietnam 73
BR - Brasile 42
DE - Germania 36
FR - Francia 33
IT - Italia 32
BJ - Benin 31
IN - India 27
KR - Corea 27
GB - Regno Unito 25
AT - Austria 19
CA - Canada 15
MX - Messico 15
BD - Bangladesh 11
ES - Italia 10
IQ - Iraq 10
JP - Giappone 10
AR - Argentina 9
PL - Polonia 9
FI - Finlandia 6
LT - Lituania 6
NL - Olanda 5
PH - Filippine 5
TR - Turchia 5
ZA - Sudafrica 5
EC - Ecuador 4
UA - Ucraina 4
PK - Pakistan 3
SE - Svezia 3
TW - Taiwan 3
CH - Svizzera 2
EG - Egitto 2
ID - Indonesia 2
LB - Libano 2
MA - Marocco 2
PY - Paraguay 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
BE - Belgio 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.547
Città #
San Jose 124
Hong Kong 91
Singapore 88
Ashburn 71
Beijing 38
Cotonou 31
Los Angeles 26
Moscow 26
Lauterbourg 21
Seoul 18
Hanoi 17
Falkenstein 15
Ho Chi Minh City 15
Brooklyn 11
Buffalo 11
Santa Clara 11
New York 9
Orem 9
Gangbuk-gu 8
Mexico City 8
São Paulo 8
Tokyo 8
Vienna 8
Warsaw 8
Chennai 7
London 7
Novara 7
Assago 6
Da Nang 6
Dallas 6
Frankfurt am Main 6
Nuremberg 6
Council Bluffs 5
Haiphong 5
Mumbai 5
Poplar 5
Tianjin 5
Toronto 5
Boston 4
Denver 4
Dhaka 4
Johannesburg 4
Manila 4
Montreal 4
Shanghai 4
Ankara 3
Baghdad 3
Casier 3
Curitiba 3
Hangzhou 3
Helsinki 3
Long Xuyen 3
Phoenix 3
Quito 3
Seattle 3
Stockholm 3
Atlanta 2
Baie-D'Urfé 2
Bengaluru 2
Botucatu 2
Bragança Paulista 2
Buenos Aires 2
Can Tho 2
Córdoba 2
Delhi 2
Elk Grove Village 2
Genoa 2
Hillsboro 2
Jakarta 2
Madrid 2
Manchester 2
Mosul 2
Providence 2
Querétaro 2
Raleigh 2
Redondo Beach 2
Sabará 2
Sona 2
Thái Bình 2
Turin 2
Turku 2
Zurich 2
Aguascalientes 1
Ahmedabad 1
Amritsar 1
Amsterdam 1
América 1
Apodaca 1
Apucarana 1
Asunción 1
Atibaia 1
Bangkok 1
Barnet 1
Basra 1
Bathgate 1
Beirut 1
Berlin 1
Bexley 1
Bishkek 1
Biên Hòa 1
Totale 892
Nome #
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 112
Immunotherapy vs Best Supportive Care for Patients with Hepatocellular Cancer with Child-Pugh B Dysfunction 86
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours 80
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 79
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma 74
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis 73
Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma 72
Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison 70
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis 70
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma 66
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma 66
The price and value of therapeutic synergy in liver cancer 64
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study 61
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events 61
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 61
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study 59
Immunotherapy Benefit Over Best Supportive Care in Hepatocellular Cancer With Child-Pugh B Dysfunction-Reply 58
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 58
ctDNA: A Gateway for Personalized Risk Stratification in Surgically Resectable Hepatocellular Cancer 57
Immunotherapy at all stages of hepatocellular carcinoma 52
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma 50
Diabetes and Immune Checkpoint Inhibitors—Response 50
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden 45
Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study 33
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence 26
Totale 1.583
Categoria #
all - tutte 5.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.109


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025400 5 0 5 2 4 7 45 106 98 37 13 78
2025/20261.183 56 33 48 120 192 102 205 182 119 126 0 0
Totale 1.583